Omeros Corp. Stock
Omeros Corp. Stock
A very strong showing by Omeros Corp. today, with an increase of €0.41 (4.520%) compared to yesterday's price.
Omeros Corp. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
Based on the current price of 9.37 € the target price of 31 € shows a potential of 230.84% for Omeros Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Omeros Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 4.520% | 12.688% | 56.427% | -9.469% | -15.964% | 388.912% | -19.502% |
| Ardelyx Inc. | -0.470% | 1.501% | -0.696% | -1.154% | 3.525% | 187.536% | -1.306% |
| Krystal Biotech | 5.350% | 6.399% | 15.665% | 18.562% | 32.194% | 164.737% | - |
| Evolus Inc | 0.890% | -5.042% | -1.739% | -52.521% | -46.190% | -16.296% | 86.346% |
Comments
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (NASDAQ:OMER) had its "strong-buy" rating reaffirmed by analysts at WBB Securities. They now have a $45.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
News
Breakout Momentum Plays You Need to Know About
Momentum investors rely on a combination of astute analysis and timing to maximize gains. While this approach can carry a fair degree of risk, the allure of identifying a fast-growing stock and
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Shares of Omeros (NASDAQ: OMER) finished Oct. 14's trading session at $4.10 per share. When the market opened on Oct. 15, the stock was up by 181% at $11.52 per share.
It was a deal with the Danish
Omeros Posts 2,652 Percent Sales Jump
Omeros (NASDAQ:OMER), a biopharmaceutical company focused on developing treatments for rare diseases and immune-related conditions, released its second quarter results on August 14, 2025. The